University of Groningenfounded in 1614  -  top 100 university
Close
Research Research database

Cancers, 2072-6694

Journal

1 - 50 out of 54Page size: 50
  1. 2021
  2. Leeuwen, van, B. (2021). Senescent Cells: A Potential Target for New Cancer Therapies in Older Oncologic Patients. Cancers.
  3. 2020
  4. Niu, F., Dzikiewicz-Krawczyk, A., Koerts, J., de Jong, D., Wijenberg, L., Fernandez Hernandez, M., Slezak-Prochazka, I., Winkle, M., Kooistra, W., van der Sluis, T., Rutgers, B., Terpstra, M. M., Kok, K., Kluiver, J., & van den Berg, A. (2020). MiR-378a-3p Is Critical for Burkitt Lymphoma Cell Growth. Cancers, 12(12), 1-18. [3546]. https://doi.org/10.3390/cancers12123546
  5. Sondorp, L. H. J., Ogundipe, V. M. L., Groen, A. H., Kelder, W., Kemper, A., Links, T. P., Coppes, R. P., & Kruijff, S. (2020). Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening. Cancers, 12(11), 1-15. [3212]. https://doi.org/10.3390/cancers12113212
  6. Weinhäuser, I., & Schuringa, J. J. (2020). Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia. Cancers, 12(11), 1-16. [3134]. https://doi.org/10.3390/cancers12113134
  7. van Eck, I., den Hollander, D., Desar, I. M. E., Soomers, V. L. M. N., van de Sande, M. A. J., de Haan, J. J., Verhoef, C., Vriens, I. J. H., Bonenkamp, J. J., van der Graaf, W. T. A., van Houdt, W. J., & Husson, O. (2020). Unraveling the Heterogeneity of Sarcoma Survivors' Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study. Cancers, 12(11), 1-21. [3083]. https://doi.org/10.3390/cancers12113083
  8. Jendryczko, K., Chudzian, J., Skinder, N., Opaliński, Ł., Rzeszótko, J., Wiedlocha, A., Otlewski, J., & Szlachcic, A. (2020). FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1. Cancers, 12(10), [12102992]. https://doi.org/10.3390/cancers12102992
  9. Wei, J., Rybczynska, A. A., Meng, P., Terpstra, M., Saber, A., Sietzema, J., Timens, W., Schuuring, E., Hiltermann, T. J. N., Groen, H. J. M., van der Wekken, A. J., van den Berg, A., & Kok, K. (2020). An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients. Cancers, 12(10), 1-17. [2843]. https://doi.org/10.3390/cancers12102843
  10. Lamy, P-J., van der Leest, P., Lozano, N., Becht, C., Duboeuf, F., Groen, H. J. M., Hilgers, W., Pourel, N., Rifaela, N., Schuuring, E., & Alix-Panabières, C. (2020). Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study. Cancers, 12(10), 1-14. [3002]. https://doi.org/10.3390/cancers12103002
  11. Zheng, G., Catalano, C., Bandapalli, O. R., Paramasivam, N., Chattopadhyay, S., Schlesner, M., Sijmons, R., Hemminki, A., Dymerska, D., Lubinski, J., Hemminki, K., & Försti, A. (2020). Cancer Predisposition Genes in Cancer-Free Families. Cancers, 12(10), 1-13. https://doi.org/10.3390/cancers12102770
  12. Ettaieb, M. H. T., van Kuijk, S. M. J., de Wit-Pastoors, A., Feelders, R. A., Corssmit, E. P. M., Eekhoff, E. M. W., van der Valk, P., Timmers, H. J. L. M., Kerstens, M. N., Klümpen, H-J., Leeuwaarde, V. R. S., Havekes, B., & Haak, H. R. (2020). Development and Internal Validation of a Multivariable Prediction Model for Adrenocortical-Carcinoma-Specific Mortality. Cancers, 12(9), 1-16. [2720]. https://doi.org/10.3390/cancers12092720
  13. Zhou, X., Zijlstra, S. N., Soto-Gamez, A., Setroikromo, R., & Quax, W. J. (2020). Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53. Cancers, 12(9), 1-15. [2514]. https://doi.org/10.3390/cancers12092514
  14. Soomers, V. L. M. N., Desar, I. M. E., van de Poll-Franse, L. V., van de Sande, M. A. J., de Haan, J. J., Verhoef, C., Vriens, I. J. H., van Houdt, W. J., Bonenkamp, J. J., van der Graaf, W. T. A., & Husson, O. (2020). The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study. Cancers, 12(8), 1-13. [2088]. https://doi.org/10.3390/cancers12082088
  15. van der Kooij, M. K., Wetzels, M. J. A. L., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Boers-Sonderen, M. J., Dierselhuis, M. P., de Groot, J. W. B., Hospers, G. A. P., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., Wouters, M. W. J. M., Haanen, J. B. A. G., van den Eertwegh, A. J. M., Bastiaannet, E., & Kapiteijn, E. (2020). Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response. Cancers, 12(8), 1-15. [2072]. https://doi.org/10.3390/cancers12082072
  16. den Toom, I. J., Boeve, K., Lobeek, D., Bloemena, E., Donswijk, M. L., de Keizer, B., Klop, W. M. C., Leemans, C. R., Willems, S. M., Takes, R. P., Witjes, M. J. H., & de Bree, R. (2020). Elective Neck Dissection or Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer Patients: The Dutch Experience. Cancers, 12(7), [1783]. https://doi.org/10.3390/cancers12071783
  17. Nieuwenhuizen, S., Puijk, R. S., van den Bemd, B., Aldrighetti, L., Arntz, M., van den Boezem, P. B., Bruynzeel, A. M. E., Burgmans, M. C., de Cobelli, F., Coolsen, M. M. E., Dejong, C. H. C., Derks, S., Diederik, A., van Duijvendijk, P., Eker, H. H., Engelsman, A. F., Erdmann, J., Futterer, J. J., Geboers, B., ... Meijerink, M. R. (2020). Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group. Cancers, 12(7), 1-17. [1779]. https://doi.org/10.3390/cancers12071779
  18. Schatz, S., Falk, M., Jóri, B., Ramdani, H. O., Schmidt, S., Willing, E-M., Menon, R., Groen, H. J. M., Diehl, L., Kröger, M., Wesseler, C., Griesinger, F., Hoffknecht, P., Tiemann, M., & Heukamp, L. C. (2020). Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer. Cancers, 12(6), 1-14. [1685]. https://doi.org/10.3390/cancers12061685
  19. Veronesi, G., Baldwin, D. R., Henschke, C. I., Ghislandi, S., Iavicoli, S., Oudkerk, M., De Koning, H. J., Shemesh, J., Field, J. K., Zulueta, J. J., Horgan, D., Fiestas Navarrete, L., Valentino Infante, M., Novellis, P., Murray, R. L., Peled, N., Rampinelli, C., Rocco, G., Rzyman, W., ... Pelosi, G. (2020). Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe. Cancers, 12(6), 1-24. [1672]. https://doi.org/10.3390/cancers12061672
  20. Podralska, M., Ciesielska, S., Kluiver, J., van den Berg, A., Dzikiewicz-Krawczyk, A., & Slezak-Prochazka, I. (2020). Non-Coding RNAs in Cancer Radiosensitivity: MicroRNAs and lncRNAs as Regulators of Radiation-Induced Signaling Pathways. Cancers, 12(6), 1-27. [1662]. https://doi.org/10.3390/cancers12061662
  21. Weber, S., Spiegl, B., Perakis, S. O., Ulz, C. M., Abuja, P. M., Kashofer, K., Leest, P. V. D., Azpurua, M. A., Tamminga, M., Brudzewsky, D., Rothwell, D. G., Mohan, S., Sartori, A., Lampignano, R., Konigshofer, Y., Sprenger-Haussels, M., Wikman, H., Bergheim, I. R., Kloten, V., ... Heitzer, E. (2020). Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling. Cancers, 12(6), 1-16. [1588]. https://doi.org/10.3390/cancers12061588
  22. Niu, F., Kazimierska, M., Nolte, I. M., Terpstra, M. M., de Jong, D., Koerts, J., van der Sluis, T., Rutgers, B., O'Connell, R. M., Kok, K., van den Berg, A., Dzikiewicz-Krawczyk, A., & Kluiver, J. (2020). The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth. Cancers, 12(6), 1-20. [1464]. https://doi.org/10.3390/cancers12061464
  23. Dias, F., Teixeira, A. L., Nogueira, I., Morais, M., Maia, J., Bodo, C., Ferreira, M., Silva, A., Vilhena, M., Lobo, J., Sequeira, J. P., Maurício, J., Oliveira, J., Kok, K., Costa-Silva, B., & Medeiros, R. (2020). Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease. Cancers, 12(6), [1450]. https://doi.org/10.3390/cancers12061450
  24. Roze, J., Monroe, G., Kutzera, J., Groeneweg, J., Stelloo, E., Paijens, S., Nijman, H., Meurs, H. V., Lonkhuijzen, L. V., Piek, J., Lok, C., Jonges, G., Witteveen, P., Verheijen, R., Haaften, G. V., & Zweemer, R. (2020). Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup. Cancers, 12(5), [1308]. https://doi.org/10.3390/cancers12051308
  25. Primavesi, F., Andreasi, V., Hoogwater, F. J. H., Partelli, S., Wiese, D., Heidsma, C., Cardini, B., Klieser, E., Marsoner, K., Froeschl, U., Thalhammer, S., Fischer, I., Goebel, G., Hauer, A., Kiesslich, T., Ellmerer, P., Klug, R., Neureiter, D., Wundsam, H., ... Staettner, S. (2020). A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort Study. Cancers, 12(5), [1235]. https://doi.org/10.3390/cancers12051235
  26. Leest, P. V. D., Boonstra, P. A., Elst, A. T., Kempen, L. C. V., Tibbesma, M., Koopmans, J., Miedema, A., Tamminga, M., Groen, H. J. M., Reyners, A. K. L., & Schuuring, E. (2020). Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients. Cancers, 12(5), [1222]. https://doi.org/10.3390/cancers12051222
  27. Blankenstein, S. A., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., Franken, M. G., de Groot, J. W. B., Haanen, J. B. A. G., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., Wouters, M. W. J. M., & van Akkooi, A. C. J. (2020). Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy. Cancers, 12(5), [1176]. https://doi.org/10.3390/cancers12051176
  28. Tamminga, M., Andree, K. C., Hiltermann, T. J. N., Jayat, M., Schuuring, E., van den Bos, H., Spierings, D. C. J., Lansdorp, P. M., Timens, W., Terstappen, L. W. M. M., & Groen, H. J. M. (2020). Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET. Cancers, 12(4), [896]. https://doi.org/10.3390/cancers12040896
  29. Leeneman, B., Uyl-de Groot, C. A., Aarts, M. J. B., van Akkooi, A. C. J., van den Berkmortel, F. W. P. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Herbschleb, K. H., van der Hoeven, J. J. M., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., Wouters, M. W. J. M., Haanen, J. B. A. G., & Franken, M. G. (2020). Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs. Cancers, 12(4), [1003]. https://doi.org/10.3390/cancers12041003
  30. Lohman, E. D. S., de Bitter, T., Verhoeven, R., van der Geest, L., Hagendoorn, J., Mohammad, N. H., Daams, F., Klumpen, H-J., van Gulik, T., Erdmann, J., de Boer, M., Hoogwater, F., Koerkamp, B. G., Braat, A., Verheij, J., Nagtegaal, I., van Laarhoven, C., van den Boezem, P., van der Post, R., & de Reuver, P. (2020). Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort. Cancers, 12(4), [918]. https://doi.org/10.3390/cancers12040918
  31. Signore, A., Lauri, C., Auletta, S., Varani, M., Onofrio, L., Glaudemans, A. W. J. M., Panzuto, F., & Marchetti, P. (2020). Radiopharmaceuticals for Breast Cancer and Neuroendocrine Tumors: Two Examples of How Tissue Characterization May Influence the Choice of Therapy. Cancers, 12(4), [781]. https://doi.org/10.3390/cancers12040781
  32. Agahozo, M. C., Timmermans, M. A. M., Sleddens, H. F. B. M., Foekens, R., Trapman-Jansen, A. M. A. C., Schröder, C. P., van Leeuwen-Stok, E., Martens, J. W. M., N M Dinjens, W., & van Deurzen, C. H. M. (2020). Loss of Y-Chromosome during Male Breast Carcinogenesis. Cancers, 12(3), [631]. https://doi.org/10.3390/cancers12030631
  33. Brahm, C. G., van Linde, M. E., Enting, R. H., Schuur, M., Otten, R. H. J., Heymans, M. W., Verheul, H. M. W., & Walenkamp, A. M. E. (2020). The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review. Cancers, 12(3), [586]. https://doi.org/10.3390/cancers12030586
  34. IJzerman, N. S., Drabbe, C., den Hollander, D., Mohammadi, M., van Boven, H., Desar, I. M. E., Gelderblom, H., Grünhagen, D. J., Reyners, A. K. L., van Noesel, M. M., Mathijssen, R. H. J., Steeghs, N., & van der Graaf, W. T. A. (2020). Gastrointestinal Stromal Tumours (GIST) in Young Adult (18-40 Years) Patients: A Report from the Dutch GIST Registry. Cancers, 12(3), [730]. https://doi.org/10.3390/cancers12030730
  35. Soto-Gamez, A., Chen, D., Nabuurs, A. G. E., Quax, W. J., Demaria, M., & Boersma, Y. L. (2020). A bispecific inhibitor of the EGFR/ADAM17 axis decreases cell proliferation and migration of EGFR-dependent cancer cells. Cancers, 12(2), [411]. https://doi.org/10.3390/cancers12020411, https://doi.org/10.3390/cancers12020411
  36. Peng, W., de Bruijn, H. S., ten Hagen, T. L. M., Berg, K., Roodenburg, J. L. N., van Dam, G. M., Witjes, M. J. H., & Robinson, D. J. (2020). In-Vivo Optical Monitoring of the Efficacy of Epidermal Growth Factor Receptor Targeted Photodynamic Therapy: The Effect of Fluence Rate. Cancers, 12(1), [190]. https://doi.org/10.3390/cancers12010190
  37. 2019
  38. Betancourt, L. H., Szasz, A. M., Kuras, M., Rodriguez Murillo, J., Sugihara, Y., Pla, I., Horvath, Z., Pawłowski, K., Rezeli, M., Miharada, K., Gil, J., Eriksson, J., Appelqvist, R., Miliotis, T., Baldetorp, B., Ingvar, C., Olsson, H., Lundgren, L., Horvatovich, P., ... Marko-Varga, G. (2019). The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma-Association with Clinical Outcome and Tumor Phenotypes. Cancers, 11(12). https://doi.org/10.3390/cancers11121981
  39. Schouwenburg, M. G., Suijkerbuijk, K. P. M., Koornstra, R. H. T., Jochems, A., van Zeijl, M. C. T., van den Eertwegh, A. J. M., Haanen, J. B. A. G., Aarts, M. J., Akkooi, A. C. J. V., Berkmortel, F. W. P. J. V. D., Groot, J. W. B. D., Hospers, G. A. P., Kapiteijn, E., Kruit, W. H., Piersma, D., van Rijn, R. S., Ten Tije, A. J., Vreugdenhil, G., Hoeven, J. J. M. V. D., & Wouters, M. W. J. M. (2019). Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH? Cancers, 11(12), [1940]. https://doi.org/10.3390/cancers11121940
  40. de Jong, M. R. W., Langendonk, M., Reitsma, B., Herbers, P., Nijland, M., Huls, G., van den Berg, A., Ammatuna, E., Visser, L., & van Meerten, T. (2019). WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage. Cancers, 11(11), [1743]. https://doi.org/10.3390/cancers11111743
  41. Berends, A. M. A., Eisenhofer, G., Fishbein, L., Horst-Schrivers, A. N. A. V. D., Kema, I. P., Links, T. P., Lenders, J. W. M., & Kerstens, M. N. (2019). Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma. Cancers, 11(8), [1121]. https://doi.org/10.3390/cancers11081121
  42. Chau, C., van Doorn, R., van Poppelen, N. M., van der Stoep, N., Mensenkamp, A. R., Sijmons, R. H., van Paassen, B. W., van den Ouweland, A. M. W., Naus, N. C., van der Hout, A. H., Potjer, T. P., Bleeker, F. E., Wevers, M. R., van Hest, L. P., Jongmans, M. C. J., Marinkovic, M., Bleeker, J. C., Jager, M. J., Luyten, G. P. M., & Nielsen, M. (2019). Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers, 11(8), [1114]. https://doi.org/10.3390/cancers11081114
  43. Mahalingam, D., Carew, J. S., Espitia, C. M., Cool, R. H., Giles, F. J., de Jong, S., & Nawrocki, S. T. (2019). Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models. Cancers, 11(7), [895]. https://doi.org/10.3390/cancers11070895
  44. Jochems, A., van der Kooij, M. K., Fiocco, M., Schouwenburg, M. G., Aarts, M. J., van Akkooi, A. C., van den Berkmortel, F. W. P. J., Blank, C. U., van den Eertwegh, A. J. M., Franken, M. G., de Groot, J. B., Haanen, J. B. A. G., Hospers, G. A. P., Koornstra, R. H., Kruit, W. H. J., Louwman, M., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., ... Kapiteijn, E. (2019). Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry. Cancers, 11(7), [1007]. https://doi.org/10.3390/cancers11071007
  45. Wang, D., Nagle, P. W., Wang, H. H., Smit, J. K., Faber, H., Baanstra, M., Karrenbeld, A., Chiu, R. K., Plukker, J. T. M., & Coppes, R. P. (2019). Hedgehog Pathway as a Potential Intervention Target in Esophageal Cancer. Cancers, 11(6), [821]. https://doi.org/10.3390/cancers11060821
  46. Ferronika, P., Hof, J., Kats-Ugurlu, G., Sijmons, R. H., Terpstra, M. M., de Lange, K., Leliveld-Kors, A., Westers, H., & Kok, K. (2019). Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour. Cancers, 11(6), [812]. https://doi.org/10.3390/cancers11060812
  47. Zhang, B., Liu, B., Chen, D., Setroikromo, R., Haisma, H. J., & Quax, W. J. (2019). Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells. Cancers, 11(5), [645]. https://doi.org/10.3390/cancers11050645
  48. Liu, B., Song, S., Setroikromo, R., Chen, S., Hu, W., Chen, D., van der Wekken, A. J., Melgert, B. N., Timens, W., van den Berg, A., Saber, A., & Haisma, H. J. (2019). CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor. Cancers, 11(4), [455]. https://doi.org/10.3390/cancers11040455
  49. Rijken, J. A., Dekkers, O. M., Niemeijer, N. D., Leemans, C. R., Eijkelenkamp, K., van der Horst-Schrivers, A. N. A., Kerstens, M. N., van Berkel, A., Timmers, H. J. L. M., Kunst, H. P. M., Bisschop, P. H. L. T., Dreijerink, K. M. A., van Dooren, M. F., Hes, F. J., Jansen, J. C., Corssmit, E. P. M., & Hensen, E. F. (2019). Increased Mortality in SDHB but Not in SDHD Pathogenic Variant Carriers. Cancers, 11(1), [103]. https://doi.org/10.3390/cancers11010103
  50. 2018
  51. Nijland, M., Seitz, A., Terpstra, M., van Imhoff, G. W., Kluin, P. M., van Meerten, T., Atayar, Ç., van Kempen, L. C., Diepstra, A., Kok, K., & van den Berg, A. (2018). Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma. Cancers, 10(11), [459]. https://doi.org/10.3390/cancers10110459
  52. de Wit, S., Zeune, L. L., Hiltermann, T. J. N., Groen, H. J. M., van Dalum, G., & Terstappen, L. W. M. M. (2018). Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis. Cancers, 10(10), [377]. https://doi.org/10.3390/cancers10100377
  53. Wei, J., van der Wekken, A. J., Saber, A., Terpstra, M. M., Schuuring, E., Timens, W., Hiltermann, T. J. N., Groen, H. J. M., van den Berg, A., & Kok, K. (2018). Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung Cancers. Cancers, 10(1), [10]. https://doi.org/10.3390/cancers10010010
  54. 2015
  55. Dohmen, A. J. C., Swartz, J. E., Van Den Brekel, M. W. M., Willems, S. M., Spijker, R., Neefjes, J., & Zuur, C. L. (2015). Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review. Cancers, 7(3), 1716-1742. https://doi.org/10.3390/cancers7030858
Previous 1 2 Next

ID: 13465724

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube